Cimzia (certolizumab pegol) is a medication used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. However, the cost of Cimzia can be high, making it challenging for patients to afford. The Cimzia Savings Program is designed to help eligible patients save on their Cimzia prescriptions.
Q: Can I re-enroll in the Cimzia Savings Program if I lose my commercial insurance? A: Yes, patients can re-enroll if their insurance status changes. cimzia savings program
Eligible patients enrolled in the Cimzia Savings Program can receive: Cimzia (certolizumab pegol) is a medication used to
The primary benefit of the Cimzia Savings Program is the improvement in medication adherence. Chronic inflammatory diseases are relentless; a lapse in medication can lead to flare-ups, irreversible joint damage, or bowel complications. By alleviating the financial pressure, the savings program removes a primary barrier to adherence. When patients can afford their prescriptions, they are more likely to maintain consistent therapeutic levels of the drug in their system, leading to better disease control and an improved quality of life. Q: Can I re-enroll in the Cimzia Savings
The Cimzia Savings Program is a patient assistance program offered by UCB, the manufacturer of Cimzia. The program aims to help eligible patients with commercial or private insurance save on their Cimzia prescriptions. The program provides discounts on Cimzia copays, coinsurance, and deductibles, making it more affordable for patients.